Novalis LifeSciences
Overview
Novalis LifeSciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science . It invests in small to medium size life science companies operating in the biopharma therapeutics, diagnostics, and life science tools sectors . The firm funds and advises visionary Life Science entrepreneurs .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Enko | Jan 2023 | Series C | Co-investor |
| Animol Discovery | Feb 2025 | Series C | Co-investor |
| Vigilant Biosciences | Nov 2019 | VC Round | Lead |
| Vizgen | Jun 2022 | Series C | Co-investor |
| Orogen Therapeutics | Jun 2023 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Novalis LifeSciences based?
Novalis LifeSciences is headquartered in Portsmouth, New Hampshire, United States.
When was Novalis LifeSciences founded?
Novalis LifeSciences was founded in 2017.
How many portfolio companies does Novalis LifeSciences have?
Novalis LifeSciences has 16 portfolio companies in Caplight's dataset.
What are some companies in Novalis LifeSciences's portfolio?
Portfolio companies visible on Caplight include Enko, Animol Discovery, Vigilant Biosciences, Vizgen, Orogen Therapeutics.
What was Novalis LifeSciences's most recent investment shown here?
Novalis LifeSciences's most recent investment in this portfolio sample was in Animol Discovery in 2025.
What sectors does Novalis LifeSciences focus on?
Novalis LifeSciences focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Novalis LifeSciences focus on?
Novalis LifeSciences typically invests at the Mid stage.
What is Novalis LifeSciences's AUM?
Novalis LifeSciences's assets under management are estimated between $500.0M and $1.0B.